Atherosclerotic renal artery stenosis: Is it worth diagnosing?

Journal of Human Hypertension

Volumn 13, Issue 4, 1999, Pages 217-220

  Eardley, K S ^a   Lipkin, G W ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Hypertension; Renal artery stenosis; Renal failure; Revascularisation

Indexed keywords

CAPTOPRIL; GADOLINIUM;

ANGIOPLASTY; ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIALYSIS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; RENOGRAPHY; REVASCULARIZATION; SHORT SURVEY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STENT;

EID: 0032946045     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000785     Document Type: Short Survey

References (33)

1. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet 1994; 344: 237-239.
2. Davis BA, Crook JE, Vestal RE, Oates JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 1979; 301: 1273-1276.
3. Greco BA, Breyer JA. Atherosclerotic ischaemic renal disease. Am J Kidney Dis 1997; 29: 167-187.
4. Scoble JE. The epidemiology and clinical manifestations of atherosclerotic renal disease. In: Novick A, Scoble J, Hamilton G (eds). Renal Vascular Disease. WB Saunders: London, 1996, pp 303-314.
5. Harden PN et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136.
6. Van Jaarsveld BC et al. The Dutch renal artery stenosis intervention cooperative (DRASTIC) study. Abstract presented at the International Society of Hypertension meeting, Amsterdam 1998.
7. Textor SC, Smith-Powell L. Pathophysiology of renal failure in ischaemic renal disease. In: Novick A, Scoble J, Hamilton G (eds). Renal Vascular Disease. WB Saunders: London, 1996, pp 289-304.
8. Farmer CKT, Reidy J, Cook G, Scoble JE. Individual kidney function is not dictated by the presence of stenosis in atherosclerotic nephropathy. Abstract presented at the Renal Asociation, Autumn meeting. London 1998.
9. Schreiber MJ, Pohl MA, Novick AL. The natural history of atherosclerotic and fibrous renal artery disease. Ural Clin North Am 1984; 11: 383-392.
10. Tollefson DFJ, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991; 14: 327-333.
11. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE. Natural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonagraphy. J Vasc Surg 1994; 19: 250-258.
12. Caps MT et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998; 53: 735-742.
13. Connolly JO et al. Presentation, clinical features, and outcome in different patterns of atherosclerotic renovascular disease. Quart J Med 1994; 87: 413-421.
14. Baboolal K, Evans L, Moore RH. Incidence of endstage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998; 31: 971-977.
15. Nally JV. Captopril renography. In: Novick A, Scoble J, Hamilton G (eds). Renal Vascular Disease. WB Saunders: London, 1996, pp 195-204.
16. Olbricht CJ, Arlart IP. Magnetic resonance angiography - the procedure of choice to diagnose renal artery stenosis? NDT 1998; 13: 1620-1622.
17. Conlon PJ et al. Survival in renal vascular disease. J Am Soc Nephrol 1998; 9: 252-256.
18. Isles C et al. Survival associated with renovascular disease in Glasgow and Newcastle: A collaborative study. Scot Med J 1990; 35: 70-73.
19. Dorros G et al. Four year follow up of Palmaz-Schatz stent renovascularisation as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98: 642-647.
20. The systolic hypertension in the elderly program (SHEP) co-operative research group prevention of stroke by antihypertensive drug treatment: Final results of SHEP. JAMA 1991; 265: 3255-3264.
21. Scandanavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S). Lancet 1994; 333: 1308-1312.
22. Kaatee R et al. Atherosclerotic renal artery stenosis: ostial or truncal? Radiology 1996; 199: 637-640.
23. Sos TA. Angioplasty for the treatment of azotemia and renovascular hypertension in atherosclerotic renal artery disease. Circulation 1991; 83 (Suppl I): 1-162-1-166.
24. Beutler JJ et al. Randomised clinical trial between stent placement and balloon angioplasty in atherosclerotic renovascular hypertension. Abstract presented at the International Society of Hypertension meeting, Amsterdam 1998.
25. Blum U et al. Treatment of ostial renal artery stenoses with vascular endoprotheses after unsuccessful balloon angioplasty. N Eng J Med 1997; 336: 459-465.
26. White CJ et al. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997; 30: 1445-1450.
27. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: An overview of published series. BMJ 1990; 300: 569-572.
28. Webster J et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 1998; 31: 823-829.
29. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. Hypertension 1998; 31: 823-829.
30. Hansen JF et al. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16: 319-331.
31. Scoble JE, Look GJR. Individual kidney function in atherosclerotic nephropathy. NDT 1998; 13: 842-844.
32. Pickering TG et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: Treatment by angioplasty or surgical revascularisation. Lancet 1988; ii: 551-552.
33. Khosla S. Effects of renal artery stent implantation in patients with unstable angina or congestive heart failure. Am J Cardiol 1997; 80: 363-366.